Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:BABY

Natus Medical (BABY) Stock Price, News & Analysis

Natus Medical logo

About Natus Medical Stock (NASDAQ:BABY)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$26.75
$31.92
52-Week Range
N/A
Volume
22 shs
Average Volume
165,325 shs
Market Capitalization
$1.12 billion
P/E Ratio
23.21
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive BABY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Natus Medical and its competitors with MarketBeat's FREE daily newsletter.

BABY Stock News Headlines

Critical AI announcement set to ignite AI 2.0
I just put together an urgent new presentation that you need to see right away. In short: I believe we are mere days away from a critical announcement from a key tech leader… One that will officially ignite “AI 2.0” – and potentially send a whole new class of stocks soaring.
See More Headlines

BABY Stock Analysis - Frequently Asked Questions

Natus Medical Inc (NASDAQ:BABY) released its quarterly earnings data on Wednesday, October, 24th. The medical equipment provider reported $0.40 EPS for the quarter, missing analysts' consensus estimates of $0.42 by $0.02. The company's quarterly revenue was up 6.5% on a year-over-year basis.

Natus Medical (BABY) raised $9 million in an IPO on Wednesday, March 8th 2023. The company issued 1,766,618 shares at $5.00 per share.

Based on aggregate information from My MarketBeat watchlists, some other companies that Natus Medical investors own include Bristol Myers Squibb (BMY), Meta Platforms (META), Starbucks (SBUX), Intel (INTC), Walt Disney (DIS), Gilead Sciences (GILD) and Activision Blizzard (ATVI).

Company Calendar

Last Earnings
10/24/2018
Today
8/03/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Electromedical Equipment
Sub-Industry
Health Care Equipment
Current Symbol
NASDAQ:BABY
CIK
878526
Fax
N/A
Employees
1,729
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
$1.42
Trailing P/E Ratio
23.21
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$22.93 million
Net Margins
-7.38%
Pretax Margin
N/A
Return on Equity
10.79%
Return on Assets
6.57%

Debt

Debt-to-Equity Ratio
0.18
Current Ratio
1.70
Quick Ratio
1.18

Sales & Book Value

Annual Sales
$530.89 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
9.39
Book Value
$11.80 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
34,010,000
Free Float
N/A
Market Cap
$1.12 billion
Optionable
Optionable
Beta
0.57
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:BABY) was last updated on 8/4/2025 by MarketBeat.com Staff
From Our Partners